Navigation Links
Nieuwe behandeloptie vandaag geïntroduceerd voor artsen die patiënten behandelen met veelvuldig recidiverend of refractair agressief B-cel-non-hodgkinlymfoom
Date:11/7/2012

SEATTLE, Washington, November 7, 2012 /PRNewswire/ --

Cell Therapeutics, Inc. ("CTI") (NASDAQ en MTA: CTIC), een bedrijf dat zich richt op het vertalen van wetenschap naar nieuwe kankertherapieën, heeft vandaag bekend gemaakt dat Pixuvri® (pixantron) in Nederland beschikbaar is. In mei 2012 is voor pixantron in de Europese Unie (EU) voorwaardelijke goedkeuring verleend en dit is de eerste, in de EU goedgekeurde behandeling voor volwassen patiënten met veelvuldig recidiverend of refractair agressief B-cel-non-hodgkinlymfoom ('NHL'). In het EXTEND (Expanding the reach of anthracyclines with piXanTronE in relapsed or refractory aggressive NHL Disease) -onderzoek naar pixantron bereikten met pixantron meer patiënten een volledige respons of niet-bevestigde volledige respons en duurde het ook langer voor hun ziekte verergerde dan met andere monotherapeutische behandelingen.[1]

"Er bestaat echt behoefte aan een nieuwe behandeloptie bij de behandeling van agressief recidiverend NHL," aldus Professor Anton Hagenbeek, hoogleraar hematologie verbonden aan het Academisch Medisch Centrum (AMC) in Nederland. "Momenteel zijn er voor patiënten die geen respons vertonen op tweedelijnsbehandeling en dus niet in aanmerking komen voor hooggedoseerde chemotherapie gevolgd door autologe stamceltransplantatie, maar beperkte opties en vaak kan hun alleen deelname aan een klinisch onderzoek of palliatieve zorg worden geboden. Pixantron is een belangrijke nieuwe ontwikkeling met objectieve responspercentages van 40% in deze specifieke subgroepen van 'poor-risk' patiënten waar zowel artsen als patiënten blij mee zullen zijn."

In de EU doen zich jaarlijks ongeveer 37.000 nieuwe gevallen van agressief B-cel-NHL voor.[2],[3] Patiënten met recidiverend/refractair NHL krijgen doorgaan
'/>"/>

SOURCE Cell Therapeutics Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 2013 First patients dosed with ... bromide designed using Prosonix, particle engineering platform ... of inhaled Respiratory Medicines by Design , has ... will assess its effect on lung function and the ... moderate to severe chronic obstructive pulmonary disease (COPD). The ...
(Date:5/21/2013)... MA (PRWEB) May 21, 2013 ... tracking to reporting eLearning solution using Tin Can ... and dashboard tool. CLD is a leading developer ... and medical device companies worldwide. , Tin ... standard that helps learners and trainers more accurately ...
(Date:5/21/2013)... 21, 2013 Alpha Source, Inc., ... will be exhibiting for the 13th consecutive year ... Instrumentation (AAMI) 2013 Conference and Expo. The conference ... and manufacture healthcare technologies. This year’s event will ... California. , The three-day event draws over ...
(Date:5/21/2013)... Clinverse, Inc. , a ... trials, announced today it has formed a strategic ... ClinPay® FLS eClinical commerce platform aggregates data collected ... SpendMD ™, Aggregate Spend Solutions’ recently-launched flagship product, ... reporting transfer of value at investigator meetings or ...
Breaking Biology Technology:Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 2CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 3Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3
(Date:5/21/2013)... A new analysis shows that the nation,s land ... enough algae to produce up to 25 billion gallons ... one-twelfth of the country,s yearly needs. , The findings ... that would be needed to grow significant amounts of ... were published in the May 7 issue of ...
(Date:5/21/2013)... class of pharmaceuticals can both prevent and treat Alzheimer,s ... "TSPO ligands," are currently used for certain types of ... ligand in young adult mice when pathology was at ... was quite severe," said lead researcher Christian Pike of ... measures of pathology and improved behavior at both ages." ...
(Date:5/21/2013)... become most deadly when they metastasize and spread tumors ... it becomes very difficult for doctors to locate and ... at the University of Missouri have found a way ... wherever they may be in the body. Michael Lewis, ... of Veterinary Medicine, says being able to target secondary ...
Breaking Biology News(10 mins):Going green: Nation equipped to grow serious amounts of pond scum for fuel 2Going green: Nation equipped to grow serious amounts of pond scum for fuel 3Going green: Nation equipped to grow serious amounts of pond scum for fuel 4Drugs found to both prevent and treat Alzheimer's disease in mice 2MU researchers develop radioactive nanoparticles that target cancer cells 2
... With more than 1.7 million people sustaining a traumatic ... to limit inflammation and subsequent damage is critical. Approximately ... leaving 85,000 with long-term disabilities and taking the lives ... live with disabilities caused by traumatic brain injuries, often ...
... (New York, NY, April 22, 2012) Researchers at ... pathway that controls the retention and release of the ... normal and abnormal neurologic development and could eventually lead ... findings, from a collaborative effort of the laboratories of ...
... in Science shows that mountain plants across the ... raised species numbers on mountain tops, when colonizers from lower ... also shows that upward shifts can lead to a reduction ... of 66 mountain summits distributed between the north of Europe ...
Cached Biology News:Estrogen hormone reveals protective ability after traumatic brain injury 2'Housekeeping' mechanism for brain stem cells discovered 2'Housekeeping' mechanism for brain stem cells discovered 3Accelerating climate change exerts strong pressure on Europe's mountain flora 2
... The T2-04 is an ultra-compact pump available in ... TH) and ideal for use in portable air ... slpm, this pump works well in environments where ... and compact size are critical., Offers ultra-compact ...
XA7 B6...
Curcumin is an extract of turmeric root with antioxidant, anti-tumor promoter, and anti-inflammatory properties. Curcumin inhibits the induction of NOS in macrophages....
... RNAi Kit is optimized for ... amounts of ready-to-use dsRNA for ... The MEGAscript RNAi Kit is ... transcription technol-ogy and includes reagents ...
Biology Products: